A potential blood test can distinguish ME/chronic fatigue syndrome with great accuracy, after years of medical uncertainty.

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to ...

HOUSTON, TEXAS / ACCESS Newswire / January 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for ar ...

The demonstrator model, based on Madrid urban conditions, is able to calculate yields but can also be used to evaluate alternative maximum power point tracking (MPPT) algorithms. The team combined ...

Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...

More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

Study in a Sentence: Cedars-Sinai researchers are developing KronosRx, an artificial intelligence-powered platform that uses human-derived organoids and deep-learning models to forecast adverse drug ...

While experimentation is essential, traditional A/B testing can be excessively slow and expensive, according to DoorDash engineers Caixia Huang and Alex Weinstein. To address these limitations, they ...

Novartis received breakthrough therapy designation from the FDA for ianalumab, a monoclonal antibody aimed at treating Sjögren’s disease. Ianalumab works by depleting B cells and blocking BAFF-R ...

People with from spinal cord injuries often lose some or all their limb function. In most patients, the nerves in their limbs work fine, and the neurons in their brain are still operational, but the ...